This article is more than 5 years old. Information may no longer be current.
ASCO elects seven to leadership roles
Peter P. Yu, MD, has been chosen as the next president-elect of ASCO.
Yu, a medical oncologist and hematologist and director of cancer research at Palo Alto Medical Foundation, will serve as ASCO president from 2014-15.
Yu, who has served as a member of several ASCO committees since 1986, is a member of the Cancer and Leukemia Group B and the Gynecologic Oncology Group. He also is co-chairman of the Commission for the Certification of Health Information Technology Oncology Workgroup.
ASCO also announced the election of three members of its board of directors, as well as three members of its nominating committee, all of whom will assume their positions in June.
The new members of the board of directors are Therese M. Mulvey, MD, FASCO, physician-in-chief at Southcoast Centers for Cancer Care in Massachusetts; Neal J. Meropol, MD, professor of medicine and chief of the division of hematology and oncology at University Hospitals Case Medical Center and Case Western University; and Paulo Marcelo Gehm Hoff, MD, PhD, FACP, professor of oncology and general director of the Instituto do Câncer do Estado de São Paulo at the University of São Paulo in Brazil.
The new members of the nominating committee are Roscoe F. Morton, MD, FACP, a partner at Medical Oncology and Hematology Associates of Iowa; Lee M. Ellis, MD, a professor of surgery and cancer biology and the William C. Liedtke Jr. Chair in cancer research at The University of Texas MD Anderson Cancer Center; and Kim Allyson Margolin, MD, associate director for the hematology-oncology fellowship training program and a professor in the division of oncology at the University of Washington and director of the University of Washington/Seattle Cancer Care Alliance clinical research program in melanoma and kidney cancer.